Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $(1.77) by 12.99 percent. This is a 53.27 percent increase over losses of $(4.28) per share from the same period last year. The company reported quarterly sales of $43.85 million which missed the analyst consensus estimate of $44.46 million by 1.39 percent. This is a 26.16 percent increase over sales of $34.76 million the same period last year.